Alzheimer's research & therapy
-
Alzheimers Res Ther · Jul 2018
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.
A growing body of evidence suggests that the plasma concentration of the neurofilament light chain (NfL) might be considered a plasma biomarker for the screening of neurodegeneration in Alzheimer's disease (AD). ⋯ This study confirms increased concentrations of plasma NfL in patients with Alzheimer's disease compared with nondemented controls.